Mark R Pittelkow Selected Research

Mark R Pittelkow Research Topics

Disease

15	Neoplasms (Cancer) 04/2020 - 02/2002
10	Melanoma (Melanoma, Malignant) 11/2020 - 01/2002
9	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2014 - 02/2004
6	Inflammation (Inflammations) 07/2022 - 04/2004
6	Pemphigus (Pemphigus Vulgaris) 11/2015 - 03/2004
5	Mycosis Fungoides 10/2021 - 06/2005
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2020 - 01/2005
4	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2002
4	Skin Diseases (Skin Disease) 04/2015 - 01/2005
4	Atopic Dermatitis (Atopic Eczema) 07/2012 - 09/2006
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2006 - 08/2004
3	Skin Neoplasms (Skin Cancer) 04/2022 - 08/2007
3	Dermatitis 03/2021 - 08/2010
3	Lymphoma (Lymphomas) 01/2021 - 06/2005
3	Celiac Disease (Celiac Sprue) 01/2015 - 02/2008
3	Acantholysis 01/2013 - 03/2004
3	Vasculitis (Vasculitides) 02/2012 - 06/2006
3	Dermatitis Herpetiformis (Disease, Duhring's) 02/2012 - 10/2004
3	Nephrogenic Fibrosing Dermopathy 01/2011 - 08/2006
2	Infections 07/2022 - 06/2002
2	Exanthema (Rash) 03/2021 - 10/2004
2	Gangrene 01/2021 - 08/2006
2	Actinic Keratosis 04/2020 - 10/2010
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2017 - 07/2002
2	Immunoglobulin G4-Related Disease 04/2015 - 02/2014
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2011 - 03/2011
2	Exfoliative Dermatitis (Erythroderma) 08/2008 - 03/2006
2	Calciphylaxis 04/2007 - 09/2004
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 06/2005 - 07/2002
2	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2005 - 12/2002
1	Pityriasis Rubra Pilaris 11/2022
1	Wounds and Injuries (Trauma) 07/2022
1	Lichen Planus (Lichen Ruber Planus) 01/2022
1	Pseudolymphoma 09/2021
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 09/2021
1	Raynaud Disease (Raynaud's Disease) 01/2021
1	Migraine Disorders (Migraine) 01/2021
1	Disease Progression 01/2021
1	Panniculitis 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Ataxia (Dyssynergia) 10/2020
1	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 10/2020
1	Lymphomatoid Papulosis 09/2020
1	Plasmablastic Lymphoma 01/2020

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 10/2020 - 01/2002
4	Pharmaceutical PreparationsIBA 11/2022 - 06/2005
4	Immunoglobulin G (IgG)IBA 02/2014 - 03/2004
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2010 - 02/2002
3	AutoantibodiesIBA 01/2013 - 03/2004
3	Glutens (Glutelin)IBA 02/2012 - 10/2004
2	Secretory Leukocyte Peptidase InhibitorIBA 07/2022 - 04/2004
2	Sunscreening Agents (Sunscreens)IBA 04/2022 - 08/2007
2	CytokinesIBA 01/2022 - 03/2010
2	Rituximab (Mabthera)FDA Link 09/2021 - 01/2019
2	Methotrexate (Mexate)FDA LinkGeneric 09/2021 - 03/2021
2	Biological ProductsIBA 10/2020 - 11/2013
2	Inositol (Myoinositol)IBA 04/2020 - 10/2010
2	Interleukin-8 (Interleukin 8)IBA 01/2020 - 12/2002
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 09/2004
2	Inositol Polyphosphate 5-PhosphatasesIBA 03/2019 - 10/2010
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2019 - 01/2005
2	Lenalidomide (CC 5013)FDA Link 08/2016 - 03/2011
2	Immunoglobulins (Immunoglobulin)IBA 04/2015 - 02/2014
2	Isotretinoin (Accutane)FDA LinkGeneric 01/2015 - 12/2014
2	Immunomodulating AgentsIBA 01/2014 - 07/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2012 - 03/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2012 - 04/2007
2	RetinoidsIBA 04/2012 - 06/2005
2	GadoliniumIBA 01/2011 - 08/2009
2	sargramostim (Leukine)FDA Link 12/2008 - 02/2002
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 12/2008 - 08/2006
2	Immunoglobulin A (IgA)IBA 02/2008 - 01/2005
2	Adrenergic Agents (Adrenergic Drugs)IBA 10/2007 - 09/2006
2	AmphiregulinIBA 06/2005 - 06/2004
1	Monoclonal AntibodiesIBA 11/2022
1	secukinumabIBA 11/2022
1	ixekizumabIBA 11/2022
1	InterleukinsIBA 11/2022
1	Antiviral Agents (Antivirals)IBA 07/2022
1	Peptide Hydrolases (Proteases)FDA Link 07/2022
1	ruxolitinibIBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	Janus Kinase 1IBA 01/2022
1	AcidsIBA 10/2021
1	mogamulizumabIBA 03/2021
1	Calcitonin Gene-Related PeptideIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	pazopanib FDA Link 01/2021
1	polyglutamineIBA 10/2020
1	Ataxin-3IBA 10/2020
1	IntegrinsIBA 01/2020

Therapy/Procedure

22	Therapeutics 09/2021 - 07/2002
3	Photopheresis 03/2021 - 02/2002
2	Photochemotherapy (Photodynamic Therapy) 10/2021 - 09/2020
2	Transplantation 01/2017 - 04/2012
2	Parathyroidectomy 10/2016 - 04/2007
2	Drug Therapy (Chemotherapy) 12/2005 - 06/2002
2	Mohs Surgery (Mohs' Micrographic Surgery) 01/2005 - 08/2004
1	Protective Clothing 04/2022
1	Surgical Amputation (Amputations) 01/2021